- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
QuantumSphere has been asked to provide a capabilities presentation and brief government technical personnel who are pursuing the use of nanomaterials in a variety of Department of Defense applications.
QuantumSphere, Inc., announced
that it will present at a private session at the Picatinny Arsenal November
19th. The invitation-only event provides leading producers of nanomaterials
with a forum to brief government officials on their products and production
capabilities. Specifically, QuantumSphere has been asked to provide a
capabilities presentation and brief government technical personnel who are
pursuing the use of nanomaterials in a variety of Department of Defense
QuantumSphere manufactures leading metallic nanopowders for breakthrough propellants, munitions and other energetic applications in the aerospace, defense, energy and other markets demanding advanced material applications.
QuantumSphere enables order-of-magnitude performance improvements for applications by using nanotechnology in existing materials to make new, revolutionary products. The news follows QuantumSphere’s previous announcement that it opened an expanded manufacturing facility in response to demand for the company’s nanoaluminum (n-Al) powder for breakthrough applications in the aerospace and defense markets.
“We are delighted to present at Picatinny Arsenal. Picatinny is the world’s leader in the research, development, engineering, and production support for advanced weapon systems,” said Kevin Maloney, CEO, QuantumSphere, Inc. “The demand for QuantumSphere’s products for breakthrough propellants and munitions for the defense, aerospace and energy markets has been immense, as QuantumSphere enables our customers to achieve results that could never be realized before,” Maloney added.
Picatinny plays a unique role in the United States’ ability to wage war. There is no other comprehensive armaments facility like it in the country. From fuses, propellants, fire control systems, and energetics to the lethal power of mortars, tanks, and artillery, Picatinny manages the process from birth to battlefield.
About QuantumSphere, Inc.
QuantumSphere manufactures leading metallic nanopowders for breakthrough propellants, munitions and other energetic applications in the aerospace, defense, energy and other markets demanding advanced material applications. QuantumSphere’s exclusive manufacturing process provides: consistent, narrow particle size distribution; low level of agglomeration and impurities; custom-tailored oxide shell thickness; and the highest purity metallic nanopowders on the market that are easier to transport and handle. The company manufactures the highest quality of metallic nanopowder in the industry without compromising its commitment to the environment.
No other company offers these performance advantages, as QuantumSphere has a 2-year lead ahead of its competitors. The company will leverage its leading market position in nanoaluminum (n-Al) to introduce nanonickel (n-Ni) applications for fuel cells, and other applications including additives for plastics and electromagnetic frequency shielding applications.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Simulations predict flat liquid May 21st, 2015
Physicists solve quantum tunneling mystery: ANU media release: An international team of scientists studying ultrafast physics have solved a mystery of quantum mechanics, and found that quantum tunneling is an instantaneous process May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
This Slinky lookalike 'hyperlens' helps us see tiny objects: The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists' ability to observe single molecules May 23rd, 2015
Nanotherapy effective in mice with multiple myeloma May 21st, 2015